Dysregulation of the AMPK-SREBP1-FASN axis in MASLD: driving a vicious cycle of lipotoxicity and metabolic-immune crosstalk.

Lipids Health Dis · 2026 · PMC12918582 · PMID 41582137

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

A fixed-dose combination of leucine, metformin, and sildenafil (NS-0200) showed a trend towards reducing liver fat in a high-dose regimen within a subgroup of patients with elevated baseline ALT in a phase 2 trial [ 76 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.